Dr. An Van Rompay
ActiveDr. An Van Rompay has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €176k and a net result of €-10k. Equity remains stable across the filed fiscal years (±1.9% per year). Its solvency ranks better than 70% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability34▼-37
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 4.22 against 4.22 in 2024; short-term debt: 19.2% and cash: 19.1% of total assets), and 19.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
25 d early
2024
9 d early
2023
57 d early
2022
55 d early
2021
26 d early
2020
9 d early
2019
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€176k▼ 5.6%
2024 · €187k
2018: €167k
2019: €154k
2020: €178k
2021: €220k
2022: €227k
2023: €201k
2024: €187k
2018 → 2025
Total assets
€218k▼ 6.1%
2024 · €232k
2018: €276k
2019: €231k
2020: €229k
2021: €269k
2022: €267k
2023: €233k
2024: €232k
2018 → 2025
Net result
€-10k
2024 · €4k
2018: €19k
2019: €33k
2020: €24k
2021: €87k
2022: €30k
2023: €520
2024: €4k
2018 → 2025
Working capital
€134k▼ 4.1%
2024 · €140k
2018: €81k
2019: €68k
2020: €81k
2021: €170k
2022: €163k
2023: €150k
2024: €140k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€220k-€227k▲ 3.5%€201k▼ 11.6%€187k▼ 7.2%€176k▼ 5.6%
Operating result€42k-€45k▲ 5.2%€3k▼ 93.9%€8k▲ 179%€-7k
Net result€87k-€30k▼ 66.1%€520▼ 98.2%€4k▲ 739%€-10k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €7k after €8k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €218k
Fixed assets
€42k▼ 13.4%
Current assets
€176k▼ 4.2%
Equity and liabilities €218k
Equity
€176k▼ 5.6%
Debt
€42k▼ 8.1%
The debt ratio falls from 19.6% to 19.2%. Equity and debt are lower.
Key figures and ratios
EBITDA
€8k▼
2024 · €21k
Cash flow
€5k▼
2024 · €18k
Solvency
80.8%▲
2024 · 80.4%
Current ratio
4.22▲
2024 · 4.22
Quick ratio
4.22▲
2024 · 4.22
Debt / equity
0.24▼
2024 · 0.24
ROE
-5.9%▼
2024 · 2.3%
ROA
-4.8%▼
2024 · 1.9%
Interest coverage
2.56▼
2024 · 8.29
Debt
€42k▼
2024 · €45k
Debt ≤ 1 year
€42k▼
2024 · €44k
Income taxes
€168▼
2024 · €729
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€232k€218k▼
Fixed assets21/28€48k€42k▼
Tangible fixed assets22/27€38k€32k▼
Land and buildings22€30k€27k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€5k€3k▼
Financial fixed assets28€10k€10k=
Current assets29/58€184k€176k▼
Amounts receivable after more than one year29€5k-
Other amounts receivable291€5k-
Amounts receivable within one year40/41€17k€25k▲
Trade receivables40€5k€9k▲
Other amounts receivable41€12k€16k▲
Current investments50/53€107k€107k=
Cash at bank and in hand54/58€52k€42k▼
Deferred charges and accrued income490/1€3k€3k▼
Equity and liabilities
Total equity and liabilities10/49€232k€218k▼
Equity10/15€187k€176k▼
Contributions10/11€19k€19k=
Reserves13€168k€166k▼
Distributable reserves133€168k€166k▼
Profit (loss) carried forward14-€-8k
Amounts payable17/49€45k€42k▼
Amounts payable after more than one year17€2k-
Other amounts payable178/9€2k-
Amounts payable within one year42/48€44k€42k▼
Trade debts44€679€289▼
Suppliers440/4€679€289▼
Taxes, remuneration and social security45-€2k
Taxes450/3-€2k
Other amounts payable47/48€43k€39k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€15k▲
Other operating charges640/8€2k€3k▲
Gross operating margin9900€23k€11k▼
Operating profit (loss)9901€8k€-7k▼
Financial income75/76B€78-
Recurring financial income75€78-
Financial charges65/66B€3k€3k▲
Recurring financial charges65€3k€3k▲
Profit (loss) for the period before taxes9903€5k€-10k▼
Income taxes67/77€729€168▼
Profit (loss) for the period9904€4k€-10k▼
Profit (loss) for the period to be appropriated9905€4k€-10k▼
Appropriation of the result
Profit (loss) to be appropriated9906€4k€-10k▼
Transfer from equity791/2€19k€2k▼
Transfer to equity691/2€4k-
To other reserves6921€4k-
Profit to be distributed694/7€19k-
Return on contributions (dividend)694€19k-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €-10k ▼339%
Net result drops to €-10k, the lowest in the series.
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
04-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
06-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
05-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2018net €87k ▲267%
Net result €87k, the highest in the series.
31-12
Financial
Equity above €200kEq €220k ▲23.3%
4 profitable years in a row build equity to €220k.
22-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
2019
23-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
25-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schilde · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Steynhoefsedreef 212970 SchildeGround area
1,975 m²
Parcel 11039A0262/00N002, Flanders. Linked by address, not a title deed.
1 establishment unit
Dokter An Van Rompay
since 20082.187.064.146
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11039A0262/00N002 | Flanders | 1,975 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Kristof Segher, Urgentiegeneeskunde
BE 0652.761.696
Merelbeke-Melle · Eq €176k
ONCOLGIC MOBILE SERVICES
BE 0500.460.117
Drogenbos · Eq €176k
LMED
BE 1010.864.813
Brussel · Eq €176k
Smile Harmony
BE 0794.522.545
Elsene · Eq €176k
MEDI GASTRO
BE 0829.540.535
Brussel · Eq €176k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,821 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-03-2008
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:an.van.rompay@pandora.be